Dergiler / Experimental Biomedical Research / 2022 / Cilt: 5 - Sayı: 2

DNA investigation in the exhaled breath condensate (EBC) in non-small cell lung cancer

Sayfa
165–174
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

The source of DNA in EBC may be considered to be pathological changes resulting from the systemic inflammatory response, apart from the localized lesion in the lungs.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Aim: Exhaled breath condensate (EBC), one of the materials which is used to detect mutations in the early period, is collected by completely non-invasive a technique which has no risk for the patient.
📊
Temel Bulgular & Veri:Methods: 26 patients with NSCLC and 20 patients without lung cancer were included in the study.
💡
Sonuç & Katkı:The source of DNA in EBC may be considered to be pathological changes resulting from the systemic inflammatory response, apart from the localized lesion in the lungs.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Aim: Exhaled breath condensate (EBC), one of the materials which is used to detect mutations in the early period, is collected by completely non-invasive a technique which has no risk for the patient. We aimed to investigate whether EBC samples are suitable for the detection of DNA or not in non-small cell lung cancer (NSCLC) and control patients. Methods: 26 patients with NSCLC and 20 patients without lung cancer were included in the study. EBC procedure was performed by the help of Eco Screen- Jaeger device in 10-15 minutes during breathing at the tidal volume. DNA was isolated using tissue spin-column DNA isolation kit in the collected EBC. Results: DNA amount was twofold high in the NSCLC group than non-cancer patients in spite of short time (p>0.05). However, in cancer group DNA amount was found lower in patients with endobronchial lesions than without endobronchial lesions (p>0.05). Although, there was no relationship between DNA amount and all of EBC collection time, collected sample amount and expiration air volume in the cancer group, a positive relations was detected between DNA amount and EBC collection time in the non-cancer group. Conclusıon: This may be explained by the pathological changes which occur at the cellular level in the lungs during cancer development process. However, it may also result from relative decrease which develops from redundancy of EBC volume in the non-cancer group. The source of DNA in EBC may be considered to be pathological changes resulting from the systemic inflammatory response, apart from the localized lesion in the lungs.

🔖

Bu Makaleye Atıf Yap

AFSİN, E., POLATLİ, M., BOZKURT, G. (2022). DNA investigation in the exhaled breath condensate (EBC) in non-small cell lung cancer. Experimental Biomedical Research, Cilt: 5 - Sayı: 2, 165–174. https://ajindex.com/articles/418479

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (13)

  1. Hastürk S, Yüksel M. Akciğer Kanserinin Moleküler Biyolojisi. Hastürk S. Akciğer Kanseri. İstanbul: Bilmedya grup, 2000. p. 1- 27. [2]Fleischhacker M, Beinert T, Possinger K. Molecular genetic characteristics of lung cancer useful as ‘real’ tumor markers? Lung Cancer. 1999
  2. 25 (1): 7-24. [3]Niklinski J, Niklinska W, Laudanski J, et al. Prognostic molecular markers in non-small cell lung cancer. Lung Cancer. 2001
  3. 34 Suppl 2:S53-58. [4]Hunt J. Exhaled breath condensate: an evolving tool for noninvasive evaluation of lung disease. J Allergy Clin Immunol. 2002
  4. 110(1):28-34. [5]Gessner C, Kuhn H, Toepfer K, et al. Detection of p53 gene mutations in exhaled breath condensate of non-small cell lung cancer patients. Lung Cancer. 2004
  5. 43(2):215-22. [6]Carpagnano GE, Spanevello A, Carpagnano F, et al. Prognostic value of Exhaled Microsatellite alterations at 3p in NSCLC patients. Lung Cancer. 2009
  6. 64 (3): 334- 40. [7]Goksel T, Akkoclu A. Turkish Thoracic Society, Lung and Pleural Malignancies Study Group. Pattern of lung cancer in Turkey, 1994-1998. Respiration. 2002
  7. 69(3):207-10. [8]Türk Toraks Derneği II. Mesleki Gelişim Kursu. http://www.toraks.org.tr/mesleki gelisim kursu/ 28-09-2009. [9]Bozkurt B, Selçuk T, Fırat P. 1972-2002 döneminde Hacettepe Üniversitesi Tıp Fakültesi Hastanesinde akciğer kanseri tanısı konulan hastaların histolojik ve epidemiyolojik değerlendirmesi. Toraks Dergisi. 2004
  8. 5 (3): 148- 53. [10] Halilçolar H, Tatar D, Ertugrul G, et al. Epidemiyoljoi. In: Akkoçlu A, Öztürk C
  9. eds. Akciğer Kanseri Multidisipliner Yaklaşım. Toraks Kitapları, Ankara: Bilimsel Tıp Yayınevi
  10. P.17- 22. [11] Arınç S, Ozvaran M, Güngör N, et al. Hastanemizde Tanı Alan Akciğer Kanserli olguların Epidemiyolojik ve Histolojik Özellikleri. Akciğer Arşivi. 2005
  11. 52 [12] Kharitonov SA, Barnes PJ. Biomarkers of some pulmonary diseases in exhaled breath. Biomarkers. 2002
  12. 7 (1): 1-32. [13] James Chung-Man HO. Study on Systemic and Airway Cytokines and Oxidative Stress in Patients with Non-small Cell Lung Cancer (NSCLC) Undergoing Surgical Lung Resections. The University of Hong Kong Last Update May 12, 2016. https://clinicaltrials.gov/ct2/show/record/N CT00956852?cond=study+on+Systemic+an d+Airway+Cytokines+and+Oxidative+Stre ss+in+Lung+Cancer+Patients+Undergoing +Surgery&draw=2&rank=1 [14] Chan HP, Tran V, Lewis C, et al. Elevated levels of oxidative stress markers in exhaled breath condensate. J Thorac Oncol. 2009
  13. 4 (2): 172-78. [15] Dalaveris E, Kere